DE60308357D1 - Zellabgabeflüssigkeit zur verhinderung von zellablagerungen in abgabesystemen - Google Patents

Zellabgabeflüssigkeit zur verhinderung von zellablagerungen in abgabesystemen

Info

Publication number
DE60308357D1
DE60308357D1 DE60308357T DE60308357T DE60308357D1 DE 60308357 D1 DE60308357 D1 DE 60308357D1 DE 60308357 T DE60308357 T DE 60308357T DE 60308357 T DE60308357 T DE 60308357T DE 60308357 D1 DE60308357 D1 DE 60308357D1
Authority
DE
Germany
Prior art keywords
cell
density
discharge fluid
dispensing systems
deposits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60308357T
Other languages
English (en)
Other versions
DE60308357T2 (de
Inventor
M Morris
C Fernandes
C Spear
A Bergan
C Gardeski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Application granted granted Critical
Publication of DE60308357D1 publication Critical patent/DE60308357D1/de
Publication of DE60308357T2 publication Critical patent/DE60308357T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fuel Cell (AREA)
  • Optical Measuring Cells (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60308357T 2002-05-22 2003-05-22 Zellabgabeflüssigkeit zur verhinderung von zellablagerungen in abgabesystemen Expired - Lifetime DE60308357T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38276402P 2002-05-22 2002-05-22
US382764P 2002-05-22
US10/442,525 US20040067221A1 (en) 2002-05-22 2003-05-21 Cell delivery fluid for prevention of cell settling in delivery system
US442525 2003-05-21
PCT/US2003/016156 WO2003099347A1 (en) 2002-05-22 2003-05-22 Cell delivery fluid for prevention of cell settling in delivery system

Publications (2)

Publication Number Publication Date
DE60308357D1 true DE60308357D1 (de) 2006-10-26
DE60308357T2 DE60308357T2 (de) 2007-09-06

Family

ID=29586968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60308357T Expired - Lifetime DE60308357T2 (de) 2002-05-22 2003-05-22 Zellabgabeflüssigkeit zur verhinderung von zellablagerungen in abgabesystemen

Country Status (9)

Country Link
US (1) US20040067221A1 (de)
EP (1) EP1506027B1 (de)
JP (1) JP2005525914A (de)
AT (1) ATE339226T1 (de)
AU (1) AU2003273131B2 (de)
CA (1) CA2486173A1 (de)
DE (1) DE60308357T2 (de)
ES (1) ES2271612T3 (de)
WO (1) WO2003099347A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287125A1 (en) * 2002-05-22 2005-12-29 Medtronic, Inc. Cell delivery fluid for prevention of cell settling in delivery system
JP5175092B2 (ja) * 2004-06-01 2013-04-03 クワラタ トレーディング リミティド 幹細胞を用いるｉｎｖｉｔｒｏ技術
KR100802011B1 (ko) 2005-08-10 2008-02-12 인하대학교 산학협력단 층분리배양법을 이용한 골수에서의 중간엽 줄기세포분리방법
US20070048288A1 (en) * 2005-08-30 2007-03-01 Lyu Suping Shear thinning polymer cell delivery compositions
JP2007175008A (ja) * 2005-12-28 2007-07-12 Hiroshima Univ 幹細胞の培養方法
US8784800B2 (en) * 2009-03-09 2014-07-22 Medtronic, Inc. Method of delivering cell therapy to a target site
GB201521784D0 (en) 2015-12-10 2016-01-27 Univ Birmingham Cell purification

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5543316A (en) * 1994-04-20 1996-08-06 Diacrin, Inc. Injectable culture medium for maintaining viability of myoblast cells
US6129761A (en) * 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
AU8401498A (en) * 1997-07-14 1999-02-10 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6171610B1 (en) * 1998-04-24 2001-01-09 University Of Massachusetts Guided development and support of hydrogel-cell compositions
GB9822158D0 (en) * 1998-10-09 1998-12-02 Nycomed Imaging As Compositions
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
JP3934539B2 (ja) * 2001-12-12 2007-06-20 独立行政法人科学技術振興機構 胎盤等由来の成体又は生後組織の前駆細胞

Also Published As

Publication number Publication date
ATE339226T1 (de) 2006-10-15
EP1506027B1 (de) 2006-09-13
US20040067221A1 (en) 2004-04-08
JP2005525914A (ja) 2005-09-02
CA2486173A1 (en) 2003-12-04
DE60308357T2 (de) 2007-09-06
EP1506027A1 (de) 2005-02-16
AU2003273131A1 (en) 2003-12-12
ES2271612T3 (es) 2007-04-16
AU2003273131B2 (en) 2007-05-03
WO2003099347A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
GR3025259T3 (en) Stable provided with manure collection pit with v-shaped bottom, and method for reducing ammonia emission
ZA200501669B (en) Advanced roller bottle system for cell and tissue culturing
WO2004044142A3 (en) Mesenchymal stem cells and methods of use thereof
ATE395934T1 (de) Verfahren zur inhibierung von gehirntumorwachstum durch verwendung von antagonisten von integrinen
BR0213200A (pt) sistemas e métodos de processamento de sangue que alternam o fluxo de componente sanguìneo e solução aditiva através de um leucofiltro alinhado
NO20061899L (no) Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon
WO2007019055A3 (en) Cell delivery fluid for prevention of cellsettling in delivery system
DE60308357D1 (de) Zellabgabeflüssigkeit zur verhinderung von zellablagerungen in abgabesystemen
EP1378800A3 (de) Entwickler-Einfüllverfahren
ATE519772T1 (de) Vorrichtung und system mit trockener kontrollgen- verstummungszusammensetzung
BR9900811A (pt) Aparelho e método para comunicação de pó a partir de uma tremonha.
HK1092507A1 (en) Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture
GB9825096D0 (en) Cells,culture methods and their uses
WO2003005972A3 (en) Method for identifying tolerance in graft recipients
MX2010001996A (es) Vehiculo para celulas que contienen colageno.
ATE374267T1 (de) Verfahren zur abscheidung von zink oder zinklegierungen
RU2006108180A (ru) Способ комплексного биотестирования воды, почвы, биологически активных веществ в фитотестах
IL165250A0 (en) Methods of donor specific crossmatching
IL179318A0 (en) Methods and devices for culturing stem cells
BRPI0417091A (pt) suporte para dispositivo distribuidor
Khew et al. Collagen-Mimetic Peptide (CΜΡ) for Integrin-Specific Cellular Recognition and Tissue Engineering
Morton et al. The effect of passaging on human osteoblast-like cells.
TW200602492A (en) Method for sending substance into cells
AU300770S (en) Underground storage tank
MY145715A (en) A culture medium and method for culturing chondrocytes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803